Table II.
Correlation of THBS1 expression with clinicopathological factors.
| Parameters | No. | Low expression | High expression | P-value |
|---|---|---|---|---|
| Age (years) | ||||
| <53 | 27 | 10 | 17 | 0.430 |
| ≥53 | 26 | 7 | 19 | |
| Gender | ||||
| Male | 37 | 9 | 28 | 0.066 |
| Female | 16 | 8 | 8 | |
| Tumor size (cm) | ||||
| ≤4 | 29 | 7 | 22 | 0.174 |
| >4 | 24 | 10 | 14 | |
| Differentiation | ||||
| Poor | 31 | 15 | 16 | 0.003a |
| Well+Moderate | 22 | 2 | 20 | |
| Tumor depth | ||||
| T1+T2+T3 | 16 | 3 | 13 | 0.172 |
| T4 | 37 | 14 | 23 | |
| Lymph node | ||||
| N0+N1 | 28 | 7 | 21 | 0.243 |
| N2+N3 | 25 | 10 | 15 | |
| Distant metastasis | ||||
| M0 | 53 | 17 | 36 | – |
| M1 | 0 | 0 | 0 | |
| Clinical stage | ||||
| I+II | 20 | 5 | 15 | 0.39 |
| III+IV | 33 | 12 | 21 | |
P-value was generated by Chi-square test.
a
P<0.05 was considered as statistically significant.